Annals of Emergency Medicine
Volume 41, Issue 1 , Pages 141-143 , January 2003

Anticoagulation or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter

References 

  1. Kannel WB, Abbott RD, Savage DD, et al.  Coronary heart disease and atrial fibrillation: The Framingham Study. Am Heart J. 1983;106:389–396
  2. Kannel WB. Epidemiology of atrial fibrillation: Risk factors and hazards. Presented at: First Virtual Congress of Cardiology; October 1, 1999-March 31, 2000; Argentina.
  3. Atrial Fibrillation Investigators . Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994;154:1449–1457
  4. McMahan DA, Smith DM, Carey MA, et al.  Risk of major hemorrhage for outpatients treated with warfarin. J Intern Med. 1998;13:311–316
  5. Moher D, Cook DJ, Eastwood S, et al.  Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Lancet. 1999;354:1896–1900

PII: S0196-0644(02)84964-2

doi: 10.1067/mem.2003.41

Annals of Emergency Medicine
Volume 41, Issue 1 , Pages 141-143 , January 2003

Article Tools